Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute ischemic stroke management.

R P Atkinson1, C DeLemos

  • 1Mercy Healthcare Sacramento, Sacramento, CA, USA. rpamd@yahoo.com

Thrombosis Research
|May 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results.

Stroke·2002
Same author

Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials.

Stroke·2001
Same author

Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke?

Neurology·2001
Same author

Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.

JAMA·2000
Same author

Acute stroke medical management.

Physical medicine and rehabilitation clinics of North America·1999
Same author

Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke.

Stroke·1999
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

Acute ischemic stroke management has advanced with thrombolytic therapy. Efficient evaluation, treatment, and supportive care within a 3-hour window are crucial for intravenous recombinant tissue plasminogen activator effectiveness.

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute ischemic stroke management has evolved with new therapeutic options.
  • The urgent nature of stroke necessitates specialized stroke teams and protocols.
  • Thrombolytic therapy offers a critical treatment window for eligible patients.

Purpose of the Study:

  • To review recent advancements in acute ischemic stroke management.
  • To highlight the importance of rapid evaluation and treatment protocols.
  • To discuss the role of supportive care and specific therapies in stroke management.

Main Methods:

  • Review of current literature on acute ischemic stroke management.
  • Analysis of treatment protocols and therapeutic interventions.

Related Experiment Videos

  • Discussion of supportive care parameters including blood pressure, electrolytes, fluids, and temperature.

    • Main Results:

    • Intravenous recombinant tissue plasminogen activator has a narrow therapeutic time window of 3 hours.
    • Rigorous management of blood pressure, electrolytes, fluids, and temperature is essential.
    • Anticoagulation has not demonstrated efficacy in preventing stroke progression or recurrence.
    • Antiplatelet therapy is considered beneficial in managing acute ischemic stroke.

    Conclusions:

    • Rapid assessment and treatment are vital for effective thrombolytic therapy in acute ischemic stroke.
    • Comprehensive supportive care is a cornerstone of stroke management.
    • Antiplatelet therapy is a recommended intervention for acute ischemic stroke patients.